What is Vertex Pharmaceuticals Inc's Market Cap?

Vertex Pharmaceuticals Inc's Market Cap is $134.1B, based on as-reported figures from SEC (XBRL) filings.

What is Vertex Pharmaceuticals Inc's Enterprise Value?

Vertex Pharmaceuticals Inc's Enterprise Value is $126.2B, based on as-reported figures from SEC (XBRL) filings.

What is Vertex Pharmaceuticals Inc's Trailing P/E?

Vertex Pharmaceuticals Inc's Trailing P/E is 30.4×, based on as-reported figures from SEC (XBRL) filings.

What is Vertex Pharmaceuticals Inc's Price / Sales?

Vertex Pharmaceuticals Inc's Price / Sales is 10.7×, based on as-reported figures from SEC (XBRL) filings.

What is Vertex Pharmaceuticals Inc's EV / Revenue?

Vertex Pharmaceuticals Inc's EV / Revenue is 10.0×, based on as-reported figures from SEC (XBRL) filings.

What is Vertex Pharmaceuticals Inc's EV / EBITDA?

Vertex Pharmaceuticals Inc's EV / EBITDA is 26.1×, based on as-reported figures from SEC (XBRL) filings.

What is Vertex Pharmaceuticals Inc's Revenue (TTM)?

Vertex Pharmaceuticals Inc's Revenue (TTM) is $12.6B, based on as-reported figures from SEC (XBRL) filings.

What is Vertex Pharmaceuticals Inc's Net Income (TTM)?

Vertex Pharmaceuticals Inc's Net Income (TTM) is $4.4B, based on as-reported figures from SEC (XBRL) filings.

What is Vertex Pharmaceuticals Inc's EBITDA?

Vertex Pharmaceuticals Inc's EBITDA is $5.0B, based on as-reported figures from SEC (XBRL) filings.

What is Vertex Pharmaceuticals Inc's Diluted EPS (TTM)?

Vertex Pharmaceuticals Inc's Diluted EPS (TTM) is 17.38, based on as-reported figures from SEC (XBRL) filings.

Vertex Pharmaceuticals Inc (VRTX) Financial Statements

Vertex Pharmaceuticals Inc

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S68LJ8

XNAS · usd

528.90▼ 17.22 (-3.15%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close546.12

Day's Range520.20 – 535.00

52-Week Range374.17 – 560.25

Volume1.1M

Avg Volume1.2M

Share Statistics

Shares Outstanding

Employees6,400

ExchangeXNAS

Listed1991-07-31

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Vertex Pharmaceuticals Inc (VRTX)

What is Vertex Pharmaceuticals Inc's Market Cap?: Vertex Pharmaceuticals Inc's Market Cap is $134.1B, based on as-reported figures from SEC (XBRL) filings.
What is Vertex Pharmaceuticals Inc's Enterprise Value?: Vertex Pharmaceuticals Inc's Enterprise Value is $126.2B, based on as-reported figures from SEC (XBRL) filings.
What is Vertex Pharmaceuticals Inc's Trailing P/E?: Vertex Pharmaceuticals Inc's Trailing P/E is 30.4×, based on as-reported figures from SEC (XBRL) filings.
What is Vertex Pharmaceuticals Inc's Price / Sales?: Vertex Pharmaceuticals Inc's Price / Sales is 10.7×, based on as-reported figures from SEC (XBRL) filings.
What is Vertex Pharmaceuticals Inc's EV / Revenue?: Vertex Pharmaceuticals Inc's EV / Revenue is 10.0×, based on as-reported figures from SEC (XBRL) filings.
What is Vertex Pharmaceuticals Inc's EV / EBITDA?: Vertex Pharmaceuticals Inc's EV / EBITDA is 26.1×, based on as-reported figures from SEC (XBRL) filings.
What is Vertex Pharmaceuticals Inc's Revenue (TTM)?: Vertex Pharmaceuticals Inc's Revenue (TTM) is $12.6B, based on as-reported figures from SEC (XBRL) filings.
What is Vertex Pharmaceuticals Inc's Net Income (TTM)?: Vertex Pharmaceuticals Inc's Net Income (TTM) is $4.4B, based on as-reported figures from SEC (XBRL) filings.
What is Vertex Pharmaceuticals Inc's EBITDA?: Vertex Pharmaceuticals Inc's EBITDA is $5.0B, based on as-reported figures from SEC (XBRL) filings.
What is Vertex Pharmaceuticals Inc's Diluted EPS (TTM)?: Vertex Pharmaceuticals Inc's Diluted EPS (TTM) is 17.38, based on as-reported figures from SEC (XBRL) filings.